Moreover, immunohistochemistry (IHC) confirmed that myeloperoxidase (MPO) and interleukin-17 (IL-17) staining were significantly higher in patients with CDI than those in healthy controls (Fig. 2C). Here, MPO is linked to clostridium difficile infection.